Back to Agenda
Evidence-Based Insights Informing Participant Compensation Strategies
Session Chair(s)
Kenneth Getz, MBA
Tufts Center for the Study of Drug Development
Tufts University School of Medicine, United States
This session presents findings from a DIA–Tufts CSDD study examining how participant compensation strategies vary across trial phases and therapeutic areas and their impact on recruitment, retention, and enrollment outcomes, with implications for protocol design and trial execution
Learning Objective : Describe how participant compensation strategies vary by trial phase and therapeutic area; Assess evidence linking compensation practices to recruitment, retention, and enrollment outcomes; Apply study insights to support consistent, ethical, and effective compensation decisions in protocol design and trial execution.
Speaker(s)
Lindsay McNair, MD, MPH, MS
Equipoise Consulting, United States
Principal Consultant
Panelist
Brittany Niland
Eli Lilly and Company, United States
Senior Director- Patient Engagement, Recruitment, Diversity & Retention
Panelist
Elizabeth Smith Morris
Suvoda, United States
Director, Product Management, Patient Engagement
Have an account?